European Urology Focus

Slides:



Advertisements
Similar presentations
Diana Cardona-Grau, Igor Sorokin, Gabriel Leinwand, Charles Welliver 
Advertisements

European Urology Focus
Volume 57, Issue 3, Pages (March 2010)
Volume 63, Issue 1, Pages (January 2013)
European Urology Focus
Volume 56, Issue 5, Pages (November 2009)
Volume 187, Issue 6, Pages (June 2012)
European Urology Focus
Impact of LUTS Using Bother Index in DAN-PSS-1 Questionnaire
Volume 55, Issue 1, Pages 1-8 (January 2009)
Volume 180, Issue 3, Pages (September 2008)
Volume 164, Issue 6, Pages (December 2000)
Volume 164, Issue 6, Pages (December 2000)
Volume 41, Issue 6, Pages (June 2002)
Volume 70, Issue 3, Pages (September 2016)
Economic Value of the Transurethral Resection in Saline System for Treatment of Benign Prostatic Hyperplasia in England and Wales: Systematic Review,
Volume 45, Issue 5, Pages (May 2004)
Volume 54, Issue 2, Pages (August 2008)
Volume 68, Issue 2, Pages (August 2015)
Volume 68, Issue 6, Pages (December 2015)
Volume 50, Issue 1, Pages (July 2006)
Volume 51, Issue 2, Pages (February 2007)
Volume 62, Issue 5, Pages (November 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
European Urology Focus
European Urology Focus
Volume 64, Issue 6, Pages (December 2013)
Volume 71, Issue 1, Pages (January 2017)
Volume 61, Issue 5, Pages (May 2012)
Volume 68, Issue 5, Pages (November 2015)
Volume 73, Issue 6, Pages (June 2018)
Volume 52, Issue 3, Pages (September 2007)
Prostate Cancer Epidemic in Sight?
Volume 53, Issue 2, Pages (February 2008)
Volume 54, Issue 4, Pages (October 2008)
Elizabeth K. Bancroft, Rosalind A. Eeles
Volume 68, Issue 5, Pages (November 2015)
The Potential of MicroRNAs as Prostate Cancer Biomarkers
Volume 59, Issue 4, Pages (April 2011)
Prostate Cancer Detection: A View of the Future
Volume 71, Issue 6, Pages (June 2017)
Counselling the Prostate Cancer Patient
Volume 66, Issue 6, Pages (December 2014)
Prostate Cancer Epidemic in Sight?
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 68, Issue 6, Pages (December 2015)
Volume 63, Issue 3, Pages (March 2013)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Tillmann Loch, Pat Fox Fulgham  European Urology 
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
The Role of Genetic Markers in the Management of Prostate Cancer
Volume 64, Issue 4, Pages (October 2013)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
Volume 53, Issue 1, Pages (January 2008)
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Volume 59, Issue 4, Pages (April 2011)
Thomas Steuber, Matthew Frank O'Brien, Hans Lilja  European Urology 
Volume 65, Issue 6, Pages (June 2014)
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Volume 68, Issue 2, Pages (August 2015)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 51, Issue 2, Pages (February 2007)
Volume 54, Issue 3, Pages (September 2008)
Does PSA Testing Influence the Natural History of Prostate Cancer?
Volume 76, Issue 1, Pages (July 2019)
Presentation transcript:

European Urology Focus A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer  Melissa Assel, Liisa Sjöblom, Teemu J. Murtola, Kirsi Talala, Paula Kujala, Ulf-Håkan Stenman, Kimmo Taari, Anssi Auvinen, Andrew Vickers, Tapio Visakorpi, Teuvo L. Tammela, Hans Lilja  European Urology Focus  DOI: 10.1016/j.euf.2017.11.002 Copyright © 2017 Terms and Conditions

Fig. 1 Flow chart of participant inclusion. ERSPC=European Randomized Study of Prostate Cancer Screening; MSP=β-microseminoprotein. European Urology Focus DOI: (10.1016/j.euf.2017.11.002) Copyright © 2017 Terms and Conditions